Skip to main content
. 2024 Sep 19;16(18):3193. doi: 10.3390/cancers16183193

Table 4.

Overview of in vitro studies related to EGCG.

Polyphenol Cell Line Concentration/
Duration
Anti-Cancer Effects Type IV Collagenase-Mediated Mechanisms Reference
EGCG
[(2 R,3 R)-3′,4′,5,5′,7-pentahydroxyflavan-3-yl 3,4,5-trihydroxybenzoate]
DU-145 2, 5, 10, 20, 40 μg/mL for 24 h not specified ↓MMP-2, -9 secretion,
activity
↓NF-κB
↓ERK-1/-2
↓p38
[46]
786-O 10, 50, 100, 200 μg/mL for 24 h with or without PMA treatment not specified ↓MMP-2, -9 activity [53]
HeLa
DoTc2-4510
SK-OV-3
10, 25, 50, 100 μM for 24 h
with or without PMA treatment
not specified ↓MMP-2 activity (HeLa, SK-OV-3)
↓MMP-9 activity (HeLa, DoTc2-4510)
[52]
SCC-9 5, 10, 15, 20 μM for 24 h
with or without PMA treatment
↓cell migration
↓cell invasion
↓MMP-2 mRNA, protein, activity
↓MMP-9 activity
↑TIMP-2 mRNA, protein
↓NF-κB protein
[62]
CL1-5 5, 10, 20, 30, 40, 50 μM for 9, 12, 16, 24 h ↓cell migration
↓cell invasion
↓MMP-2 mRNA, protein, activity, promoter activity
↓MMP-9 mRNA, protein, activity
↓NF-κB nuclear translocation
[60]
SW-1353, HT-1080, SW-872, SW-982 10, 25, 50, 100 μM for 24 h
with or without PMA treatment
not specified ↓MMP-2, -9 activity [51]
U2 OS
RD
10, 25, 50, 100 μM for 24 h
with or without PMA treatment
not specified ↓MMP-2 activity
↓MMP-9 activity
[50]
TW01 (EBV-negative)
NA (EBV-positive, reinfected TW01)
10, 20, 30, 50 μM for 9, 12, 24, 48 h (cells)
1, 2.5, 5, 10, 25 μM for 7 days (spheroid)
↓spheroid formation
↓cell migration
↓cell invasion
↓proliferation
↓MMP-2 mRNA, activity
↓MMP-9 activity
↓pERK-1/-2 protein
[61]
786-O
ACHN
10, 20, 40 μg/mL for 24 h ↓cell migration
↓cell invasion
↓MMP-2, -9 activity, protein [55]
HuCC-T1 0.1, 0.5, 1, 5, 10, 20, 50 μg/mL for 24 h ↓cell migration
↓cell invasion
↑apoptosis
↓MMP-2 activity
↓MMP-9 activity
[56]
SW780 12.5, 25, 50, 100 μM for 24 h ↓cell invasion
↓cell migration
↓proliferation
↑apoptosis
↓MMP-9 mRNA, protein
↓pNF-κB p65 protein
↓NF-κB mRNA
[57]
A-2058 10, 25, 50, 100 μM for 24 h not specified ↓MMP-2, -9 activity [48]
FaDu
SCC-25
10, 25, 50, 100 μM for 24 h
with or without PMA treatment
not specified ↓MMP-2, -9 activity [49]
NPC-39
HONE-1
NPC-BM
6, 12, 25, 50 μM for 12, 24 h ↓cell migration
↓cell invasion
↓MMP-2 activity, protein [54]
A549
H1299
20, 80, 160 μM for 24, 48 h
or 20 μM with 0,625, 1.25, 2.5, 5 μM of BAY11-7082 for 24, 48 h
↓proliferation
↑apoptosis
↓cell invasion
↓cell migration
↓MMP-2 mRNA
↓NF-κB, pNF-κB mRNA, protein
[59]
A549
H1299
12.5, 25 μM for 48 h (free EGCG or PLGA-encapsulated EGCG) ↓proliferation
↑apoptosis
↓MMP-2 mRNA
↓NF-κB, pNF-κB protein
[58]

Legend: ↑ activation or increase; ↓ inhibition or decrease.